CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Return
4.23%
This Quarter Return
+19.3%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.75B
AUM Growth
+$73.2M
(+4.4%)
Cap. Flow
-$159M
Cap. Flow
% of AUM
-9.12%
Top 10 Holdings %
Top 10 Hldgs %
69.04%
Holding
38
New
9
Increased
6
Reduced
9
Closed
8
Top Buys
| 1 |
BLUE
bluebird bio
BLUE
|
$77.8M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$67.1M |
| 3 |
Viatris
VTRS
|
$51.5M |
| 4 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$39.3M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$32.5M |
Top Sells
| 1 |
AbbVie
ABBV
|
$91.4M |
| 2 |
Ventas
VTR
|
$87.1M |
| 3 |
HCA Healthcare
HCA
|
$76.4M |
| 4 |
Biogen
BIIB
|
$63.3M |
| 5 |
Sarepta Therapeutics
SRPT
|
$52.1M |
Sector Composition
| 1 | Healthcare | 86.98% |
| 2 | Technology | 10.19% |
| 3 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNTA
26
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $15M | 0.86% |
450,000
-1,550,000
| -78% | -$51.6M |
|
|
CBIO
27
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $11.3M | 0.65% |
30,000
-5,000
| -14% | -$1.88M |
|
|
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
| $5.11M | 0.29% |
+375,000
| New | +$5.11M |
|
29
Sutro Biopharma
STRO
$89.9M
| $4.66M | 0.27% |
600,000
| – | – |
|
|
30
AbbVie
ABBV
$375B
| – | – |
-1,200,000
| Closed | -$91.4M |
|
|
31
Biogen
BIIB
$20.6B
| – | – |
-200,000
| Closed | -$63.3M |
|
|
32
HCA Healthcare
HCA
$98.5B
| – | – |
-850,000
| Closed | -$76.4M |
|
33
Incyte
INCY
$16.9B
| – | – |
-360,457
| Closed | -$26.4M |
|
34
Pacific Biosciences
PACB
$381M
| – | – |
-2,500,000
| Closed | -$7.65M |
|
35
Tenet Healthcare
THC
$17.3B
| – | – |
-3,500,000
| Closed | -$50.4M |
|
|
36
Ventas
VTR
$30.9B
| – | – |
-3,250,000
| Closed | -$87.1M |
|
|
NUVA
37
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-33,630
| Closed | -$1.7M |
|